产品编号 | BIO0979SM |
英文名称 | Anti-4-1BB & PD-L1 Reference Antibody (Enristomig Biosimilar) |
别 名 | TNFRSF9 / 4-1BB / CD137 & B7-H1 / PD-L1 / CD274; Enristomig |
抗体来源 | |
克隆类型 | Monoclonal |
交叉反应 | Human |
产品应用 |
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
理论分子量 | 101.9kDa |
性 状 | Lyophilized |
亚 型 | VHH-VHH-Fc |
纯化方法 | Protein A |
缓 冲 液 | 100 mM Pro-Ac 20mM Arg pH 5.0 |
保存条件 | -80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions;Avoid repeated freeze-thaw cycles. |
注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
PubMed | PubMed |
产品介绍 | |
产品图片 |
Inbrx-105 bound to huPD-L1-CHO-K cells, and then rebounded to fluorescent secondary antibodies(Anti-Human IgG, Fcγ PE) , and test by flow cytometry. As shown in fig, Inbrx-105 bound to huPD-L1-CHO-K cells, and the EC50 was 1.186 nM.
Inbrx-105 bound to hu4-1BB-CHO-K cells, and then rebounded to fluorescent secondary antibodies(Anti-Human IgG, Fcγ PE) , and test by flow cytometry. As shown in fig, Inbrx-105 bound to hu4-1BB-CHO-K cells, and the EC50 was 3.156 nM.
Inbrx-105 bound to PD-L1 protein, and then rebounded to secondary antibodies(Anti-Human-IgG-Fc-HRP) , and read OD450. As shown in fig, Inbrx-105 bound to hu-PD-L1-His, and the EC50 was 0.008 nM.
Inbrx-105 bound to 4-1BB protein, and then rebounded to secondary antibodies(Anti-Human-IgG-Fc-HRP) , and read OD450. As shown in fig, Inbrx-105 bound to Human 4-1BB-His, and the EC50 was 0.014 nM.
|
1、抗体溶解方法 | |
2、抗体修复方式 | |
3、常用试剂的配制 | |
4、免疫组化操作步骤 | |
5、免疫组化问题解答 | |
6、Western Blotting 操作步骤 | |
7、Western Blotting 问题解答 | |
8、关于肽链的设计 | |
9、多肽的溶解与保存 | |
10、酶标抗体效价测定程序 | |